Showing results (1541-1550 of 1,810) with videos related to
Sort By:
Pageof 181
Beilstein Journal of Organic Chemistry|June 6, 2019
Novel (2-amino-4-arylimidazolyl)propanoic acids and pyrrolo[1,2-c]imidazoles via the domino reactions of 2-amino-4-arylimidazoles with carbonyl and methylene active compoundsVictoria V Lipson, Tetiana L Pavlovska, Nataliya V Svetlichnaya, et al.Archives of Pathology & Laboratory Medicine|May 1, 2015
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment optionsJeffrey S Ross, Sunil Badve, Kai Wang, et al.The European Respiratory Journal|April 18, 2020
The effect of exacerbation history on outcomes in the IMPACT trialDavid M G Halpin, Mark T Dransfield, MeiLan K Han, et al.Cancer Immunology Research|January 14, 2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survivalEvan J Lipson, Jeremy G Vincent, Myriam Loyo, et al.Nature Biotechnology|September 15, 2022
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencingSean K Simmons, Gila Lithwick-Yanai, Xian Adiconis, et al.Optics Express|May 15, 2020
Performance scaling of a 10-GHz solid-state laser enabling self-referenced CEO frequency detection without amplificationLéonard M Krüger, Aline S Mayer, Yoshitomo Okawachi, et al.JAMA|April 27, 1979
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancerM H Cohen, P B Chretien, D C Ihde, et al.International Journal of Chronic Obstructive Pulmonary Disease|December 17, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY ModelSoham Shukla, Dhvani Shah, Alan Martin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of responseJ E Stein, A Soni, L Danilova, et al.Journal of Geriatric Oncology|March 19, 2026
Cardiac risk, outcomes, and management among older adults with stage I-II non-small cell lung cancer undergoing stereotactic body radiation therapyLeah L Thompson, Sanjana B Shah, Austin T Gregg, et al.Pageof 181